Georgia’s medical cannabis program has crossed 40,000 registered patients in the few weeks since new rules took effect July 1, an increase of nearly 10%.
The surge is one of the strongest periods of growth seen in Georgia medical marijuana since a low-THC program launched in 2023, according to 11Alive. Now that THC caps have been lifted and flower and vapes are available, the new patient interest means more tangible business opportunities in the limited-license state.
Under SB 220, which Gov. Brian Kemp signed into law in May:
- Cannabis patients can now possess up to 12 grams of THC, with no THC percentage cap on products
- Vaporizable products, including flower, will be allowed for patients 21 and over
- More medical conditions will qualify a patient for enrollment, including lupus
Supporters said the new eligibility rules and products on offer would encourage patients to participate in what had been a low participation program. And so far, that prediction has come true.
As of March, there were only 34,500 registered patients out of a statewide population of 11.3 million – the lowest adoption rate of any MMJ program in the country, The Current reported at the time.
Registry data from the Georgia Department of Public Health shows about 4,700 patients enrolled in the weeks following the law change – more than 10% of the total number of patients, 11Alive reported.
What are the new rules for Georgia medical cannabis?
Judson Hill, president of the Fine Fettle Dispensary, said the newly legalized products are driving sales.
“July 1 was by far our busiest day, we had folks lined up an hour before we opened our doors,” he told 11Alive.
The updated rules also expanded the qualifying conditions list to include cancer, multiple sclerosis, Parkinson’s disease, sickle cell anemia and lupus, among others.
Cultivators also can start selling to pharmacies that have pursued U.S. Drug Enforcement Administration registration as part of medical cannabis’ reclassification as a Schedule 3 drug.
Why does the growth matter?
For operators, a rapidly expanding patient base signals a larger addressable market.
Currently, the state limits business licenses to:
- Six cultivation licenses
- 15 retail licenses, six of which are held by Trulieve
- One independent cannabis testing laboratory
For every 10,000 new medical marijuana patients entering the program, an additional retail license becomes available.
Georgia licensed a limited number of companies to produce and sell low-THC oil, so each new registrant adds demand within a tightly controlled supply chain. More patients could push existing licensees to scale production and open additional dispensing locations across the state.
Subscribe to the MJBiz Factbook
Exclusive industry data and analysis to help you make informed business decisions and avoid costly missteps. All the facts, none of the hype.
What you will get:
- Monthly and quarterly updates, with new data & insights
- Financial forecasts + capital investment trends
- State-by-state guide to regulations, taxes & market opportunities
- Annual survey of cannabis businesses
- Consumer insights
- And more!
Georgia has moved cautiously on cannabis compared with neighboring states, and a sudden climb in registrations suggests pent-up demand that the previous rules kept in check.
Whether the current pace holds or levels off will depend on how quickly physicians adopt the new certification authority. And how the state manages the influx. Supply constraints could test the market if enrollment continues at this rate.
